|
|
|
|
LEADER |
00962cas#a2200313#a#4500 |
001 |
018373 |
005 |
20160923115336.0 |
008 |
061108c1986####xx#br#p#######0####|eng#d |
022 |
|
|
|a 0258-851X
|
040 |
|
|
|a AR-beUNQ
|
099 |
|
|
|a P-GR-INV1
|
210 |
1 |
0 |
|a In vivo
|
245 |
1 |
0 |
|a In vivo :
|c International Institute of Anticancer Research.
|
260 |
|
|
|a Athens :
|b In vivo,
|
300 |
|
|
|a v :
|
310 |
|
|
|a Bimensual
|
362 |
0 |
|
|a Vol. 17, no. 1 (Jan.-Feb. 2003)
|
500 |
|
|
|a Descripción basada en: Vol. 17, no. 1 (Jan.-Feb. 2003).
|
650 |
|
7 |
|a Medicina
|2 Spines
|
650 |
|
7 |
|a Biología
|2 Spines
|
650 |
|
7 |
|a Farmacología
|2 Spines
|
650 |
|
7 |
|a Toxicología
|2 Spines
|
650 |
|
7 |
|a Terapia con medicamentos
|2 Spines
|
650 |
|
7 |
|a Cáncer
|2 toit
|
653 |
|
|
|a Oncología
|
710 |
2 |
|
|a International Institute of Anticancer Research.
|
866 |
|
0 |
|a 2003 17(1)
|
929 |
|
|
|d 0
|b Laboratorio de Oncología Molécular
|a DONACION
|j 3957100001
|e 20050526
|
999 |
|
|
|c 27509
|d 110315
|